Skip to main content
Back to sections

Silence Therapeutics plc

For the period ended Dec 31, 2023. Filed Mar 13, 2024.

View on SEC.gov

About this filing

The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.

FY2023 · Filed Mar 13, 2024

SLN$19.73+0.1%Stored close · as of Nov 6, 2026
Opening this filing…

The words and numbers in each frame are the filing's, as the company filed them with the SEC. Where a filing is data, we made the labels and headings from its field names, and added commas to its long numbers. This is not investment advice.